Litcius/Paper detail

Convalescent Plasma Therapy for Corona Virus Disease 2019: a Long Way to Go but Worth Trying

Jin‐Hong Yoo

2020Journal of Korean Medical Science16 citationsDOIOpen Access PDF

Abstract

As of 3 April, the number of patients with corona virus disease 2019 (COVID-19) in Korea has exceeded 10,000. The incidence of COVID-19 patients still shows no sign of diminishing. Now is the time to prepare for the protracted war ahead. Hence we need to find a specific treatment measure against COVID-19. Regrettably, however, no definite treatment has been available yet. Nevertheless, various treatments, including old and new antiviral agents, are currently being investigated. 1 As one of them, convalescent plasma administration has been carefully proposed. 2,3

Topics & Concepts

Convalescent plasmaMedicineCoronavirus disease 2019 (COVID-19)Ebola virusIntensive care medicineDiseaseSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)VirusVirologyIncidence (geometry)ImmunologyInternal medicineInfectious disease (medical specialty)PhysicsOpticsCOVID-19 Clinical Research StudiesSARS-CoV-2 and COVID-19 ResearchLong-Term Effects of COVID-19
Convalescent Plasma Therapy for Corona Virus Disease 2019: a Long Way to Go but Worth Trying | Litcius